Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
IR Contact
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Press Releases
Other News
May 30 2023
Lytix Biopharma’s innovative and unique solution emphasized in national clinical research report
Read more...
May 12 2023
Hear our CEO, Øystein Rekdal, explaining how our technology has the potential to solve the major challenge in current cancer therapy
Read more...
May 08 2023
"Norwegian cancer medicine is attracting attention", read article in TV2 news
Read more...
Apr 12 2023
First patient dosed in Part 2 of Verrica Pharmaceuticals' Phase II study evaluating LTX-315
Read more...
Mar 22 2023
Lytix Biopharma appoints Karsten Bruins Slot as Director Clinical Development
Read more...